Logo for Behind The Money with the Financial Times podcast

The name “Sackler” adorns museums and art galleries around the world. But the family name has also become tainted by its association with the US opioid crisis, amid accusations that OxyContin, more than any other drug, is responsible for sparking one of the worst public health epidemics of modern times. The FT's David Crow explains how the Sackler family company Purdue Pharma got its hold on the opioid market.  

Get alerts on when a new story is published

Copyright The Financial Times Limited 2018. All rights reserved.

Comments have not been enabled for this podcast.

Follow the topics in this podcast